CURIS — Curis Lifesciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Curis Lifesciences, fiscal year end - March 31st, millions except per share.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | |
| Standards: | — | IAS | IAS | IAS | IAS |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Net Income/Starting Line | — | 12.3 | 21.7 | 72 | 89.9 |
| Depreciation | |||||
| Non-Cash Items | — | 16.2 | 13 | 8.37 | 10.9 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | 13.5 | -8.43 | -84.4 | -128 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | 49.5 | 33.5 | 2.8 | -20.3 |
| Capital Expenditures | — | -3.99 | -6.23 | -0.731 | -0.93 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.266 | 0.762 | 0.115 | 0.695 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -3.73 | -5.47 | -0.616 | -0.235 |
| Financing Cash Flow Items | — | -16.2 | -13.3 | -8.49 | -11.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | -45.8 | -27.6 | 0.468 | 19.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | -0.054 | 0.414 | 2.65 | -1.14 |